查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433344

2023-2030 年全球血流動力學監測市場

Global Hemodynamic Monitoring Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030年），全球血流動力學監測市場將以 5.2% 的CAGR成長。市場的成長歸因於醫療保健支出的增加。對醫療保健基礎設施和技術的投資不斷增加有助於推動血流動力學監測產業向前發展。根據MDPI（開放取用期刊出版商）2023年2月發布的報告指出，血流動力學監測取得了長足的發展，但由於可用於診斷和治療的資料量有限，仍然存在一些問題。此外，對於什麼是「健康」血壓 (BP) 範圍存在一些爭論，最近的研究結果表明，65 毫米汞柱平均動脈壓 (MAP) 閾值應被視為預防低血壓的絕對最低值。然而，這與液體/升壓藥物治療方案中個人化血壓閾值的發展相矛盾。此外，雖然監測微循環仍然是一個繁瑣的過程，但在敗血症的情況下，微循環功能被發現是分離的。此外，需要及早發現低風險情況下的病情惡化，由於病房監測不足，每年全球有 420 萬例患者在手術後 30 天內死亡。現有的病房測量誤報率仍高達90%。這進一步強調需要利用有限的資訊來管理血流動力學不穩定的患者。

區隔市場前景

全球血流動力學監測市場根據系統、產品和最終用戶進行區隔。依系統，市場分為微創監測系統、侵入式監測系統、非侵入性監測系統等。根據產品，市場分為一次性用品和監視器。此外，根據最終用戶，市場區隔為醫院、診所和門診護理中心、門診護理中心、家庭護理機構等。在該產品中，顯示器區隔市場預計將佔據很大一部分市場佔有率。這是由於主要製造商在開發以患者為中心的護理方面不斷增加投資，並向市場推出技術改進的產品正在推動對血流動力學監測儀的需求。

預計非侵入性監測系統區隔市場將在全球血流動力學監測市場中佔據相當大的佔有率

其中，非侵入性監測系統區隔市場預計將在全球血流動力學監測市場中佔據相當大的佔有率。區隔市場的成長歸因於全球使用的技術和方法。非侵入性監測系統涵蓋多種技術，例如阻抗心動圖、超音波心動圖和脈搏輪廓分析。每種方法都有優點和缺點。例如，它們易於使用並減少患者痛苦，但無法像熱稀釋等侵入性方法那樣精確，特別是在心血管功能受損的情況下。據美國國立衛生研究院 (gov.) 稱，2021 年 10 月，對 84 名心臟衰竭患者進行了一項研究，以評估非侵入性血流動力學監測技術的準確性。大多數患者為 NYHA III 級和 IV 級，平均射血分數為 27%。結果表明，非侵入性心輸出量測量不如熱稀釋法精確，熱稀釋法被認為高估了。這一結果與其他研究一致，這些研究表明，在心輸出量減少和周邊血管阻力增加的情況下，非侵入性血流動力學監測方法不太準確。這些見解可能有助於解釋為什麼加護病房收治的重症病患的測量結果不準確。

區域展望

全球血流動力學監測市場根據地理位置進一步區隔，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於美國患有慢性疾病的人口老化不斷增加，加上ICU和急診室血流動力學監測系統的使用增加，預計北美將在全球市場中佔據顯著佔有率。推動北美市場成長。

亞太地區全球血流動力學監測市場預計將以顯著的CAGR成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於該地區演算法和資料分析的不斷進步。演算法創新（例如 Mostcare Up 強調的個人）證明了資料分析在血流動力學監測中的價值。預計這種模式將繼續下去，重點是更複雜和更精確的分析方法。例如，2023 年 4 月，Vygon India 在印度北部重症醫學會 (ISCCM) 研討會期間推出了先進的血流動力學監測系統 Mostcare Up。 Mostcare Up 是一款微創動脈壓監測儀，採用基於壓力記錄分析方法 (PRAM) 的專利演算法。它是唯一能夠即時監測每次心跳的微小血流動力學變化的監測儀。

市場參與者展望

服務全球血流動力學監測市場的主要公司包括 Deltex Medical Ltd.、Drager、Edwards Lifesciences Corp.、GE HealthCare Technologies Inc.、Getinge AB 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022 年 1 月，Sensydia 推出的心臟性能系統 (CPSTM) 已獲得美國食品藥物管理局 (FDA) 授予的突破性設備稱號。作為突破性器械認定的一部分，FDA 打算與 Sensydia 密切合作，加快 CPS 開發並優先評估後續監管提交的評估。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個區隔市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球血流動力學監測市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵區隔市場來分析業務策略。
  • 市場進入和市場擴張策略分析。透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依區隔
    • 依地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Argon Medical Devices, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
    • Baxter International, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Change Healthcare
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場區隔

  • 依系統分類的全球血流動力學監測市場
    • 微創監測系統
    • 侵入式監測系統
    • 非侵入式監測系統
    • 其他（整體監控系統、監控設備和耗材）
  • 依產品分類的全球血流動力學監測市場
    • 免洗用品
    • 顯示器
  • 依最終用戶分類的全球血流動力學監測市場
    • 醫院
    • 診所及門診護理中心
    • 門診護理中心
    • 家庭護理設置
    • 其他（研究和學術機構、製藥和生物技術公司）

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Deltex Medical Ltd.
  • Drager
  • Edwards Lifesciences Corp.
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hemo Sapiens Inc.
  • ICU Medical, Inc
  • Masimo Corp.
  • Nihon Kohden
  • Nonin Medical, Inc.
  • Philips International B.V.
  • Schwarzer Cardiotek GmbH
  • Tensys Medical Inc.
  • Terumo Group
Product Code: OMR2027945

Global Hemodynamic Monitoring Market Size, Share & Trends Analysis Report by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems, and others), by Product (Disposables and Monitors), and by End-User (Hospitals, Clinics & Ambulatory Care Centers, Ambulatory Care Centers, Home Care Settings, and Others), Forecast Period (2023-2030)

The global hemodynamic monitoring market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market's growth is attributed to the increasing healthcare expenditure. Growing investments in healthcare infrastructure and technologies help to propel the hemodynamic monitoring industry forward. According to the MDPI (Publisher of Open Access Journals), published a report in February 2023, which states that hemodynamic monitoring has seen a great deal of development, though there are still some issues owing to the limited amount of data available for diagnosis and treatment. Furthermore, there is some debate over what is considered a "healthy" blood pressure (BP) range, and recent findings suggest that a 65-mmHg mean arterial pressure (MAP) threshold should be regarded as an absolute minimum to prevent hypotensive conditions. However, this contradicts the movement towards personalized BP thresholds in fluid/vasopressor therapy protocols. Additionally, microcirculatory function has been found to be dissociated in cases of sepsis, though monitoring the microcirculation is still a tedious process. Furthermore, there is a need for earlier detection of deterioration in low-acuity settings, with 4.2 million cases of patient mortality within 30 days after surgery globally each year owing to insufficient ward monitoring. Existing ward measurements still have a false alarm rate of 90%. This further emphasizes the need for managing hemodynamically unstable patients with limited information.

Segmental Outlook

The global hemodynamic monitoring market is segmented based on the system, product, and end-user. Based on the system, the market is sub-segmented into minimally invasive monitoring systems, invasive monitoring systems, non-invasive monitoring systems, and others. Based on the product, the market is sub-segmented into disposables and monitors. Further, based on the end-user, the market is sub-segmented into hospitals, clinics & ambulatory care centers, ambulatory care centers, home care settings, and others. Among the product, monitors sub-segment is expected to capture a significant portion of the market share. This is attributed to the increasing investment by major manufacturers in developing patient-centric care and releasing technologically improved products to market is driving the demand for hemodynamic monitors.

The Non-invasive Monitoring Systems Sub-Segment is Anticipated to Hold a Considerable Share of the global Hemodynamic Monitoring Market

Among the system, the non-invasive monitoring systems sub-segment is expected to hold a considerable share of the global hemodynamic monitoring market. The segmental growth is attributed to technology and methods used across the globe. Non-invasive monitoring systems encompass various technologies such as impedance cardiograph, echocardiography, and pulse contour analysis. Each method has advantages and disadvantages. For instance, they offer ease of use and reduced patient distress, cannot be as precise as invasive methods like thermodilution, particularly in cases of impaired cardiovascular function. According to the National Institute of Health (gov.), in October 2021, a study of 84 heart failure patients was conducted to assess the accuracy of non-invasive hemodynamic monitoring techniques. The majority of patients were NYHA III and IV with a mean ejection fraction of 27%. The results showed that the non-invasive measurements of cardiac output were not as precise as the thermodilution method, that was found to be overestimating. This result is consistent with other studies which have shown that non-invasive hemodynamic monitoring methods are less accurate in cases of decreased cardiac output and increased peripheral vascular resistance. These insights might help explain why there is inaccuracy in measurements of patients in critical condition admitted in intensive care units.

Regional Outlook

The global hemodynamic monitoring market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increasing aging population in the US suffering from chronic diseases, in addition to the increased usage of hemodynamic monitoring systems in ICUs and emergency rooms, are driving North American market growth.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Hemodynamic Monitoring Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising advancements in algorithms and data analytics across the region. Algorithm innovations, such as individuals highlighted by Mostcare Up, demonstrate the value of data analytics in hemodynamic monitoring. The pattern is expected to continue, with an emphasis on more complex and precise analytical methods. For instance, in April 2023, Vygon India, launched advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium. Mostcare Up is a minimally invasive arterial pressure monitor that is powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor capable of monitoring even minor hemodynamic variations in real time and from beat to beat.

Market Players Outlook

The major companies serving the global hemodynamic monitoring market include Deltex Medical Ltd., Drager, Edwards Lifesciences Corp., GE HealthCare Technologies Inc., Getinge AB and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Sensydia, launched Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). As part of its Breakthrough Device Designation, the FDA intends to work closely with Sensydia to expedite CPS development and prioritize the assessment of subsequent regulatory submissions.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global hemodynamic monitoring market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Argon Medical Devices, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
    • 3.2.5. Baxter International, Inc.
    • 3.2.6. Overview
    • 3.2.7. Financial Analysis
    • 3.2.8. SWOT Analysis
    • 3.2.9. Recent Developments
  • 3.3. Change Healthcare
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Hemodynamic Monitoring Market by System
    • 4.1.1. Minimally Invasive Monitoring Systems
    • 4.1.2. Invasive Monitoring Systems
    • 4.1.3. Non-invasive Monitoring Systems
    • 4.1.4. Others (Total Monitoring Systems, and Monitoring Devices & Consumables)
  • 4.2. Global Hemodynamic Monitoring Market by Product
    • 4.2.1. Disposables
    • 4.2.2. Monitors
  • 4.3. Global Hemodynamic Monitoring Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Clinics and Ambulatory Care Centers
    • 4.3.3. Ambulatory Care Centers
    • 4.3.4. Home Care Settings
    • 4.3.5. Others (Research & Academic Institutes, and Pharmaceutical & Biotechnology Companies)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Deltex Medical Ltd.
  • 6.2. Drager
  • 6.3. Edwards Lifesciences Corp.
  • 6.4. GE HealthCare Technologies Inc.
  • 6.5. Getinge AB
  • 6.6. Hemo Sapiens Inc.
  • 6.7. ICU Medical, Inc
  • 6.8. Masimo Corp.
  • 6.9. Nihon Kohden
  • 6.10. Nonin Medical, Inc.
  • 6.11. Philips International B.V.
  • 6.12. Schwarzer Cardiotek GmbH
  • 6.13. Tensys Medical Inc.
  • 6.14. Terumo Group

LIST OF TABLES

  • 1. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 2. GLOBAL MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NON-INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHERS HEMODYNAMIC MONITORING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 7. GLOBAL HEMODYNAMIC DISPOSABLES MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL HEMODYNAMIC MONITORS MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL HEMODYNAMIC MONITORING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL HEMODYNAMIC MONITORING FOR CLINICS AND AMBULATORY CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL HEMODYNAMIC MONITORING FOR AMBULATORY CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL HEMODYNAMIC MONITORING FOR HOME CARE SETTINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL HEMODYNAMIC MONITORING FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT,2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 20. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 22. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 23. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT ,2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY SYSTEM, 2022 VS 2030 (%)
  • 2. GLOBAL MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NON-INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 7. GLOBAL HEMODYNAMIC DISPOSABLES MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL HEMODYNAMIC MONITORS MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 10. GLOBAL HEMODYNAMIC MONITORING FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL HEMODYNAMIC MONITORING FOR CLINICS AND AMBULATORY CARE CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL HEMODYNAMIC MONITORING FOR AMBULATORY CARE CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL HEMODYNAMIC MONITORING FOR HOME CARE SETTINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL HEMODYNAMIC MONITORING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)